Akorn, Inc. 

(Public, NASDAQ:AKRX)   Watch this stock   
Find more results for AKRX
Nov 10, 2009
Q3 2009 Earnings Conference Call
Nov 10, 2009
Q3 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -26.33% -8.48%
Operating margin -19.80% -7.67%
EBITD margin - -2.81%
Return on average assets -27.06% -9.38%
Return on average equity -47.82% -12.59%
Employees 351 -

Address

2500 Millbrook Drive
Buffalo Grove, IL 60089
United States - Map
+1-847-2796100 (Phone)
+1-847-2796123 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Akorn, Inc. discussed on blogs

Ranking Healthcare Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 19, 2009

Akorn, Inc. discussions

  View all discussions »

Description

Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines purchased from outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations and other pharmaceutical companies. It has a wholly owned subsidiary named Akorn (New Jersey), Inc., which operates in Somerset, New Jersey and is involved in manufacturing, product development, and administrative activities related to its ophthalmic and hospital drugs & injectables segments. The Company operates in four segments: ophthalmic, hospital drugs & injectables, biologics & vaccines and contract services.

Officers and directors

John N. Kapoor Ph.D.
Chairman of the Board
Age: 65
Bio & Compensation - Reuters
Rajat Rai
Interim Chief Executive Officer
Age: 42
Bio & Compensation - Reuters
Timothy A. Dick
Chief Financial Officer
Age: 39
Bio & Compensation - Reuters
Mark M. Silverberg
Executive Vice President - Operations, Global Quality Assurance, and Technical Services
Age: 55
Bio & Compensation - Reuters
Joseph P. Bonaccorsi
Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation - Reuters
John R. Sabat
Senior Vice President - National Accounts and Trade Relations
Age: 60
Bio & Compensation - Reuters
Jerry N. Ellis
Director
Age: 71
Bio & Compensation - Reuters
Ronald M. Johnson
Director
Age: 64
Bio & Compensation - Reuters
Subhash V. Kapre Ph.D.
Director
Age: 61
Bio & Compensation - Reuters
Randall J. Wall
Director
Age: 62
Bio & Compensation - Reuters